Published on
Sep 3, 2025
Dr Olmos on the Prognostic Implications of Data From the CAPTURE Study for BRCA-Mutant mHSPC
"We have to monitor these patients more closely and maybe cannot rely solely on PSA [levels] because these patients tend to progress much earlier, even with lower PSA values. That is very important." David Olmos, MD, PhD, medical oncologist, …
Source:
OncLive
-
Pending
